| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $226K | — | -1.7% |
| R&D Expense | $33.8M | — | +24.1% |
| SG&A Expense | $11.3M | — | -21.2% |
| Operating Income | -$44.9M | — | -8.6% |
| Interest Expense | $15K | — | — |
| Pre-tax Income | -$42.6M | — | -14.1% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$20.0M | — | -19.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $101.9M | -6.1% | +4.2% |
| Current Assets | $234.9M | -16.3% | -34.7% |
| Total Assets | $292.8M | -12.8% | -27.9% |
| Current Liabilities | $25.9M | -15.6% | -21.0% |
| Total Liabilities | $29.7M | -14.7% | -17.7% |
| Stockholders' Equity | -$1.02B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$41.7M | — | -40.9% |
| Capital Expenditures | $3.8M | — | +233.5% |
| Investing Cash Flow | $34.8M | — | +23.1% |
| Financing Cash Flow | $215K | — | +1891.7% |
| Free Cash Flow | -$45.5M | — | -48.0% |
| -2.5% |